Knowledge Center
Article / Mar 08, 2017
Expanding the Commercial Options
Source:
Pharma's Almanac, Q1 2017, Mar 8, 2017
Spray drying (SD) and hot-melt extrusion (HME) are commercially proven and accepted amorphous solid dispersion (ASD) technologies for the enhancement of the dissolution and bioavailability of poorly soluble drugs. These approaches are not suitable for all APIs, however. Hovione, in addition to offering non-ASD solutions such as nanomilling and cyclodextrin complexation, is developing an effective coprecipitation technology platform to address this key market need.
Related links
Also in the Knowledge Center
/ Feb 12, 2021
Webinar - From Lab to Commercial: Fully Integrated Solutions for Dry Powder Inhalation
Read more
Scientific Article
/ Feb 02, 2022
Webinar - Process safety evaluation and scale-up resorting to mechanistic modelling for exothermic and gas releasing reactions
Read more
Scientific Article
/ Feb 24, 2022
Webinar - Spray Drying Development: From Lab to Production – How to de-risk your process
Read more
Scientific Article